John Collins

Practice Areas

A leading litigator in the Intellectual Property & Technology space, with special expertise in international disputes in innovation-focused industries such as pharmaceuticals, biotech, medical devices, competition law, software development and telecommunications.

John is the National Practice Group Leader of the IP & Technology team.

Work Highlights

Novartis AG: acting in proceedings to enforce for blockbuster multiple sclerosis drugs Gilenya, Entresto, Stalevo, Aclasta, Zometa.

Sandoz: acting in the long-running Lundbeck escitalopram (Lexapro) patent infringement litigation.

Fresenius Kabi: acting in proceedings against Samsung Bioepis in connection with adalimumab

Expert witness: acting as an expert witness on Australian patent law in US arbitral proceedings concerning Gilead’s HIV drug portfolio.

Merck Sharp & Dohme: acting in competition litigation against BMS concerning blockbuster Keytruda.

Apple: acted in connection with patent disputes against Chinese smartphone manufacturers

AT&T: acted in contract dispute with local technology transfer.

nbn, Optus and Telstra: acted in various patent and contract disputes concerning DPUs, compression and content technologies.

GME: acted successfully in Federal Court registered design infringement proceedings.

Industry Sector Expertise

Copyright

Intellectual Property

Litigation and Dispute Resolution

Telecommunications Media and Technology

Trade Marks